Healthy Clinical Trial
— CIT-CRCPOfficial title:
Comparison of the InstaTemp MD® Infrared Thermometer With Standard Thermometry in Canadian Routine Clinical Practice
Verified date | January 2021 |
Source | ARC Devices |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Compare and assess the accuracy and reliability of the InstaTemp MD® device to techniques presently in use for measuring temperature in infants and children in a Canadian clinical setting.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | May 8, 2018 |
Est. primary completion date | May 8, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 1 Month to 10 Years |
Eligibility | Inclusion Criteria: - Children Age 1 month to = 10 years old - Male or female - Subject's parent or legal guardian over the age of 18 years must sign an informed consent form before any study-related procedures are performed - Subjects who in the opinion of the investigator (or as required by the ethics committee) have the capacity to understand and sign an assent form, must provide written assent Exclusion Criteria: - Subjects who in the opinion of the researcher are too agitated, distressed or who are otherwise unable to cooperate with study procedures - Subjects whose forehead cannot be fully exposed to the ambient condidtions for at least 15 minutes. - Subjects with signs or recent history of inflammation or infection of the forehead or at the reference clinical test site. - Subjects currently using cooling blankets or fans - Subjects with tubes in their ear(s) cannot participate in the tympanic comparison, but this is not exclusionary for InstaTemp MD and definitive comparator (e.g. rectal or oral) measurements. - Subjects currently receiving treatment with thyroxine, barbiturates, antipsychotics, cortico-steroids (oral iv, or topically applied to forehead) - Subjects currently alcohol intoxicated - Subjects with documented illicit durg use in the previous 5 days - Subjects that have had any hot or cold drinks within 15 minutes prior to a sublingual reading - Subject is taking any medication that in the opinion of the investigator may alter the temperature of the child - Subjects participating in a clinical trial of an investigational medicinal product within the last 30 days. |
Country | Name | City | State |
---|---|---|---|
Canada | Agoo Children's Health and Wellness Centre | Laval | Quebec |
Canada | Center for Pediatric Excellence | Ottawa | Ontario |
Lead Sponsor | Collaborator |
---|---|
ARC Devices |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Temperature measurements using "Welch Allyn" (oral/rectal), Covidien (tympanic) and ARC InstaTempMD (non-touch, infrared) in degrees Celcius and will be compared with three consecutive measurements with each thermometer. | Compare the compendia thermometers in each age range to the InstaTemp MD to determine average clinical bias. | Participant will only be required to attend one visit which will last up to a maximum of 30 minutes for the duration of the study. | |
Secondary | Mean Comparison Analysis. Temperature measurements using "Welch Allyn" (oral/recta.), Covidien (tympanic) and ARC InstaTemp MD (non-touch, infrared) in degrees Celcius and will be compared with three consecutive measurements with each thermometer. | To determine the precision of the InstaTemp MD compared to the compendia thermometers based on three consecutive measurements with each thermometer. | Participant will only be required to attend one visit which will last up to a maximum of 30 minutes for the duration of the study. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |